97 related articles for article (PubMed ID: 38566104)
1. Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI.
Mathew Thomas V; Chigarira B; Gebrael G; Sayegh N; Tripathi N; Nussenzveig R; Jo Y; Dal E; Galarza Fortuna G; Li H; Sahu KK; Srivastava A; Maughan BL; Agarwal N; Swami U
JCO Precis Oncol; 2024 May; 8():e2300574. PubMed ID: 38781543
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for prostate cancer racial disparities.
Singh SK; Lillard JW; Singh R
Front Biosci (Landmark Ed); 2017 Jan; 22(3):428-450. PubMed ID: 27814623
[TBL] [Abstract][Full Text] [Related]
3. Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.
Ramakrishnan S; Cortes-Gomez E; Athans SR; Attwood KM; Rosario SR; Kim SJ; Mager DE; Isenhart EG; Hu Q; Wang J; Woloszynska A
Genome Med; 2024 Apr; 16(1):52. PubMed ID: 38566104
[TBL] [Abstract][Full Text] [Related]
4. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
[TBL] [Abstract][Full Text] [Related]
5. The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response.
Berchuck JE; Adib E; Abou Alaiwi S; Dash AK; Shin JN; Lowder D; McColl C; Castro P; Carelli R; Benedetti E; Deng J; Robertson M; Baca SC; Bell C; McClure HM; El Zarif T; Davidsohn MP; Lakshminarayanan G; Rizwan K; Skapura DG; Grimm SL; Davis CM; Ehli EA; Kelleher KM; Seo JH; Mitsiades N; Coarfa C; Pomerantz MM; Loda M; Ittmann M; Freedman ML; Kaochar S
Cancer Res; 2022 Aug; 82(16):2848-2859. PubMed ID: 35731919
[TBL] [Abstract][Full Text] [Related]
6. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients.
Stevens C; Hightower A; Buxbaum SG; Falzarano SM; Rhie SK
Front Oncol; 2023; 13():1079037. PubMed ID: 36937425
[TBL] [Abstract][Full Text] [Related]
7. A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer.
Ylitalo EB; Thysell E; Landfors M; Brattsand M; Jernberg E; Crnalic S; Widmark A; Hultdin M; Bergh A; Degerman S; Wikström P
Clin Epigenetics; 2021 Jun; 13(1):133. PubMed ID: 34193246
[TBL] [Abstract][Full Text] [Related]
8. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
[TBL] [Abstract][Full Text] [Related]
9. Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer.
Creighton CJ; Zhang F; Zhang Y; Castro P; Hu R; Islam M; Ghosh S; Ittmann M; Kwabi-Addo B
Epigenetics; 2023 Dec; 18(1):2180585. PubMed ID: 37279148
[TBL] [Abstract][Full Text] [Related]
10. Serum Androgen Metabolites Correlate with Clinical Variables in African and European American Men with Localized, Therapy Naïve Prostate Cancer.
Ramakrishnan S; Kittles RA; Huss WJ; Wang J; Attwood K; Woloszynska A
Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837903
[TBL] [Abstract][Full Text] [Related]
11. Association of Neighborhood Deprivation With Prostate Cancer and Immune Markers in African American and European American Men.
Pichardo MS; Minas TZ; Pichardo CM; Bailey-Whyte M; Tang W; Dorsey TH; Wooten W; Ryan BM; Loffredo CA; Ambs S
JAMA Netw Open; 2023 Jan; 6(1):e2251745. PubMed ID: 36662526
[TBL] [Abstract][Full Text] [Related]
12. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
13. Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men.
Basourakos SP; Gulati R; Vince RA; Spratt DE; Lewicki PJ; Hill A; Nyame YA; Cullen J; Markt SC; Barbieri CE; Hu JC; Trapl E; Shoag JE
NEJM Evid; 2022 Jun; 1(6):. PubMed ID: 35721307
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of GATA5 Inhibits Prostate Cancer Progression by Regulating PLAGL2 via the FAK/PI3K/AKT Pathway.
Wang Q; Liu Z; Zhai G; Yu X; Ke S; Shao H; Guo J
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565203
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
